The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo

Cancer Letters

Volumn 245, Issue 1-2, 2007, Pages 81-89

  Ko, Shun Yao ^a   Chang, Kuo Wei ^b   Lin, Shu Chun ^b   Hsu, Hui Chuan ^c   Liu, Tsung Yun ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Executive Yuan   (Taiwan)

Author keywords

APP; Cancer; Carcinogenesis; Mouth; Tea

Indexed keywords

AMYLOID PRECURSOR PROTEIN; EPIGALLOCATECHIN GALLATE; GREEN TEA EXTRACT; N BENZYL N METHYLNITROSAMINE; POLYPHENOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CARCINOGENESIS; CARCINOMA CELL; CHEEK POUCH; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG PROTEIN BINDING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYRIAN HAMSTER; TEA; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CATECHIN; CELL LINE, TUMOR; CRICETINAE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESOCRICETUS; MOUTH MUCOSA; MOUTH NEOPLASMS; PHYTOTHERAPY; PLANT PREPARATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEA;

CRICETINAE;

EID: 33845602008     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.12.029     Document Type: Article

References (53)

1. Adhami V.M., Ahmad N., and Mukhtar H. Molecular targets for green tea in prostate cancer prevention. J. Nutr. 133 (2003) 2417S-2424S
2. Balentine D.A., Wiseman S.A., and Bouwens L.C. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37 (1997) 693-704
3. Chang K.W., Sarraj S., Lin S.C., Tsai P.I., and Solt D. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis. Carcinogenesis 21 (2000) 1441-1451
4. Hsu S.D., Singh B.B., Lewis J.B., Borke J.L., Dickinson D.P., Drake L., et al. Chemoprevention of oral cancer by green tea. Gen. Dent. 50 (2002) 140-146
5. Ju J., Hong J., Zhou J.N., Pan Z., Bose M., Liao J., et al. Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65 (2005) 10623-10631
6. Lambert J.D., Hong J., Yang G.Y., Liao J., and Yang C.S. Inhibition of carcinogenesis by polyphenols: evidence from laboratory investigations. Am. J. Clin. Nutr. 81 (2005) 284S-291S
7. Masuda M., Suzui M., Lim J.T., Deguchi A., Soh J.W., and Weinstein I.B. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. J. Exp. Ther. Oncol. 2 (2002) 350-359
8. Masuda M., Suzui M., Lim J.T., and Weinstein I.B. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clin. Cancer Res. 9 (2003) 3486-3491
9. Pilorget A., Berthet V., Luis J., Moghrabi A., Annabi B., and Beliveau R. Medulloblastoma cell invasion is inhibited by green tea (-)epigallocatechin-3-gallate. J. Cell. Biochem. 90 (2003) 745-755
10. Khafif A., Schantz S.P., Al-Rawi M., Edelstein D., and Sacks P.G. Green tea regulates cell cycle progression in oral leukoplakia. Head Neck 20 (1998) 528-534
11. Elattar T.M., and Virji A.S. Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro. Anticancer Res. 20 (2000) 3459-3465
12. Cao Y., and Cao R. Angiogenesis inhibited by drinking tea. Nature 398 (1999) 381
13. Hsu S., Yu F.S., Lewis J., Singh B., Borke J., Osaki T., et al. Induction of p57 is required for cell survival when exposed to green tea polyphenols. Anticancer Res. 22 (2002) 4115-4120
14. Babich H., Krupka M.E., Nissim H.A., and Zuckerbraun H.L. Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity. Toxicol. In Vitro 19 (2005) 231-242
15. Li N., Chen X., Liao J., Yang G., Wang S., Josephson Y., et al. Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23 (2002) 1307-1313
16. Li N., Han C., and Chen J. Tea preparations protect against DMBA-induced oral carcinogenesis in hamsters. Nutr. Cancer 35 (1999) 73-79
17. Pietrzik C.U., Hoffmann J., Stober K., Chen C.Y., Bauer C., Otero D.A., et al. From differentiation to proliferation: the secretory amyloid precursor protein as a local mediator of growth in thyroid epithelial cells. Proc. Natl Acad. Sci. USA 95 (1998) 1770-1775
18. Hoffmann J., Twiesselmann C., Kummer M.P., Romagnoli P., and Herzog V. A possible role for the Alzheimer amyloid precursor protein in the regulation of epidermal basal cell proliferation. Eur. J. Cell Biol. 79 (2000) 905-914
19. Meng J.Y., Kataoka H., Itoh H., and Koono M. Amyloid beta protein precursor is involved in the growth of human colon carcinoma cell in vitro and in vivo. Int. J. Cancer 92 (2001) 31-39
20. Hansel D.E., Rahman A., Wehner S., Herzog V., Yeo C.J., and Maitra A. Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation. Cancer Res. 63 (2003) 7032-7037
21. Ko S.Y., Lin S.C., Chang K.W., Wong Y.K., Liu C.J., Chi C.W., et al. Increased expression of amyloid precursor protein in oral squamous cell carcinoma. Int. J. Cancer 111 (2004) 727-732
22. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., et al. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25 (2005) 8807-8814
23. Shabany K., Chiu P.C., Raghian A., Chang K.W., and Solt D.B. Rapid in vivo assay for topical oral cancer chemopreventive agents. Int. J. Oncol. 21 (2002) 159-164
24. Ko S.Y., Lin S.C., Chang K.W., Liu C.J., Chang S.S., Lu S.Y., et al. Modulation of KGF-1 gene expression in oral fibroblasts by ripe areca nut extract. J. Oral Pathol. Med. 32 (2003) 399-407
25. Nobori T., Miura K., Wu D.J., Lois A., Takabayashi K., and Carson D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368 (1994) 753-756
26. Hsu S., Lewis J.B., Borke J.L., Singh B., Dickinson D.P., Caughman G.B., et al. Chemopreventive effects of green tea polyphenols correlate with reversible induction of p57 expression. Anticancer Res. 21 (2001) 3743-3748
27. Yang C.S., Liao J., Yang G.Y., and Lu G. Inhibition of lung tumorigenesis by tea. Exp. Lung Res. 31 (2005) 135-144
28. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 25-54
29. Lin S.C., Li W.C., Shih J.W., Hong K.F., Pan Y.R., and Lin J.J. The tea polyphenols EGCG and EGC repress mRNA expression of human telomerase reverse transcriptase (hTERT) in carcinoma cells. Cancer Lett. (2006)
30. Schmitz A., Tikkanen R., Kirfel G., and Herzog V. The biological role of the Alzheimer amyloid precursor protein in epithelial cells. Histochem. Cell Biol. 117 (2002) 171-180
31. Popp G.M., Graebert K.S., Pietrzik C.U., Rosentreter S.M., Lemansky P., and Herzog V. Growth regulation of rat thyrocytes (FRTL-5 cells) by the secreted ectodomain of beta-amyloid precursor-like proteins. Endocrinology 137 (1996) 1975-1983
32. Herzog V., Kirfel G., Siemes C., and Schmitz A. Biological roles of APP in the epidermis. Eur. J. Cell Biol. 83 (2004) 613-624
33. Bergman A., Religa D., Karlstrom H., Laudon H., Winblad B., Lannfelt L., et al. APP intracellular domain formation and unaltered signaling in the presence of familial Alzheimer's disease mutations. Exp. Cell Res. 287 (2003) 1-9
34. Rossjohn J., Cappai R., Feil S.C., Henry A., McKinstry W.J., Galatis D., et al. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat. Struct. Biol. 6 (1999) 327-331
35. Cao X., and Sudhof T.C. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293 (2001) 115-120
36. Narindrasorasak S., Altman R.A., Gonzalez-DeWhitt P., Greenberg B.D., and Kisilevsky R. An interaction between basement membrane and alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. Lab. Invest. 72 (1995) 272-282
37. Narindrasorasak S., Lowery D., Gonzalez-DeWhitt P., Poorman R.A., Greenberg B., and Kisilevsky R. High affinity interactions between the Alzheimer's beta-amyloid precursor proteins and the basement membrane form of heparan sulfate proteoglycan. J. Biol. Chem. 266 (1991) 12878-12883
38. Narindrasorasak S., Lowery D.E., Altman R.A., Gonzalez-DeWhitt P.A., Greenberg B.D., and Kisilevsky R. Characterization of high affinity binding between laminin and Alzheimer's disease amyloid precursor proteins. Lab. Invest. 67 (1992) 643-652
39. Schubert D., and Behl C. The expression of amyloid beta protein precursor protects nerve cells from beta-amyloid and glutamate toxicity and alters their interaction with the extracellular matrix. Brain Res. 629 (1993) 275-282
40. Kamal A., Almenar-Queralt A., LeBlanc J.F., Roberts E.A., and Goldstein L.S. Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP. Nature 414 (2001) 643-648
41. Quast T., Wehner S., Kirfel G., Jaeger K., De Luca M., and Herzog V. sAPP as a regulator of dendrite motility and melanin release in epidermal melanocytes and melanoma cells. Fed. Am. Soc. Exp. Biol. J. 17 (2003) 1739-1741
42. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., et al. Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl Acad. Sci. USA 96 (1999) 3922-3927
43. Buxbaum J.D., Liu K.N., Luo Y., Slack J.L., Stocking K.L., Peschon J.J., et al. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273 (1998) 27765-27767
44. Siemes C., Quast T., Klein E., Bieber T., Hooper N.M., and Herzog V. Normalized proliferation of normal and psoriatic keratinocytes by suppression of sAPPalpha-release. J. Invest. Dermatol. 123 (2004) 556-563
45. Kirfel G., Borm B., Rigort A., and Herzog V. The secretory beta-amyloid precursor protein is a motogen for human epidermal keratinocytes. Eur. J. Cell Biol. 81 (2002) 664-676
46. Wehner S., Siemes C., Kirfel G., and Herzog V. Cytoprotective function of sAppalpha in human keratinocytes. Eur. J. Cell Biol. 83 (2004) 701-708
47. Tripodi S.A., Civitelli S., Schurfeld K., and Cintorino M. Microcystic adenoma of the pancreas (glycogen-rich cystadenoma) with stromal amyloid deposits. Histopathology 37 (2000) 147-149
48. Sah J.F., Balasubramanian S., Eckert R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279 (2004) 12755-12762
49. Liberto M., and Cobrinik D. Growth factor-dependent induction of p21 (CIP1) by the green tea polyphenol, epigallocatechin gallate. Cancer Lett. 154 (2000) 151-161
50. Lin S.C., Lu S.Y., Lee S.Y., Lin C.Y., Chen C.H., and Chang K.W. Areca (betel) nut extract activates mitogen-activated protein kinasesand NF-kappaB in oral keratinocytes. Int. J. Cancer (2005)
51. Aguirre-Ghiso J.A., Estrada Y., Liu D., and Ossowski L. ERK (MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38 (SAPK). Cancer Res. 63 (2003) 1684-1695
52. Slack B.E., Breu J., Muchnicki L., and Wurtman R.J. Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C. Biochem. J. 327 Pt 1 (1997) 245-249
53. Tsubono Y., Nishino Y., Komatsu S., Hsieh C.C., Kanemura S., Tsuji I., et al. Green tea and the risk of gastric cancer in Japan. N. Engl. J. Med. 344 (2001) 632-636